Market Currents
Biogen (BIIB +0.7%) moves up after Deutsche Bank says it conducted a survey and found that 40% -...
-
Monday, April 30, 2012, 11:08 AM ETBiogen (BIIB +0.7%) moves up after Deutsche Bank says it conducted a survey and found that 40% - 57% of patients taking Baxter's (BAX +0.1%) Advate would consider switching to BIIB's new hemophilia treatment if the price was right.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
